Verano Holdings (VRNO) Current Assets (2021 - 2026)
Verano Holdings' (VRNO) quarterly Current Assets came in at $394.5 million in Q1 2026, up 9.24% year-on-year from $361.1 million in Q1 2025, and down 2.5% on a QoQ basis from $404.7 million in Q4 2025.
Verano Holdings (VRNO) Current Assets (2021 - 2026) Analysis & Trends
Verano Holdings (VRNO) has 6 years of Current Assets data on file, last reported at $394.5 million in Q1 2026.
- On a quarterly basis, Current Assets rose 9.24% year-over-year to $394.5 million in Q1 2026; TTM through Mar 2026 was $394.5 million, a 9.24% increase from a year earlier, with the FY2025 full-year figure at $404.7 million, up 11.58% from the prior year.
- Current Assets for Q1 2026 stood at $394.5 million, down from $404.7 million in the prior quarter.
- Over the last five years, Current Assets for VRNO reached as high as $418.8 million in Q1 2024 and fell as low as $288.0 million in Q2 2022.
- Historically, Current Assets has averaged $353.9 million across 5 years, with a median of $359.4 million in 2024.
- Across the five-year window, Current Assets surged 32.63% in 2024 and fell 13.76% in 2025, its largest moves.
- Year by year, Current Assets stood at $318.3 million in 2022, then climbed by 23.85% to $394.2 million in 2023, then dropped by 8.0% to $362.7 million in 2024, then gained by 11.58% to $404.7 million in 2025, then fell by 2.5% to $394.5 million in 2026.
- Per Business Quant data, the three most recent Current Assets figures were $394.5 million in Q1 2026, $404.7 million in Q4 2025, and $385.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 6.05 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 13.71 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 6.47 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 19.71 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 2.87 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 53.60 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 10.92 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 2.44 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 3.58 Bn |
| 10 | Verano Holdings | 2.02 Bn | 1.94 Bn | 98.98 Mn | 394.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 394.52 Mn |
| Dec 31, 2025 | 404.65 Mn |
| Sep 30, 2025 | 385.43 Mn |
| Jun 30, 2025 | 371.36 Mn |
| Mar 31, 2025 | 361.14 Mn |
| Dec 31, 2024 | 362.65 Mn |
| Sep 30, 2024 | 321.72 Mn |
| Jun 30, 2024 | 357.56 Mn |
| Mar 31, 2024 | 418.78 Mn |
| Dec 31, 2023 | 394.20 Mn |
| Sep 30, 2023 | 355.00 Mn |
| Jun 30, 2023 | 318.93 Mn |
| Mar 31, 2023 | 315.76 Mn |
| Dec 31, 2022 | 318.28 Mn |
| Sep 30, 2022 | 295.07 Mn |
| Jun 30, 2022 | 287.96 Mn |
| Dec 31, 2021 | 277.04 Mn |